These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 18229399)

  • 1. New test captures women's hearts.
    Johns Hopkins Med Lett Health After 50; 2007 Sep; 19(7):1-2. PubMed ID: 18229399
    [No Abstract]   [Full Text] [Related]  

  • 2. New tool refines heart risk prediction. Adding C-reactive protein and family history modernizes and improves the standard risk tool.
    Harv Heart Lett; 2007 May; 17(9):4-5. PubMed ID: 17517984
    [No Abstract]   [Full Text] [Related]  

  • 3. Why does C-reactive protein predict coronary events?
    Kushner I; Elyan M
    Am J Med; 2008 Jul; 121(7):e11. PubMed ID: 18589040
    [No Abstract]   [Full Text] [Related]  

  • 4. New test may help determine atherosclerosis risk.
    Harv Heart Lett; 2001 Oct; 12(2):1-2. PubMed ID: 11684486
    [No Abstract]   [Full Text] [Related]  

  • 5. Limitations of the Framingham risk score are now much clearer.
    Schlendorf KH; Nasir K; Blumenthal RS
    Prev Med; 2009 Feb; 48(2):115-6. PubMed ID: 19124038
    [No Abstract]   [Full Text] [Related]  

  • 6. C-reactive protein: crystal ball or redundancy? Is this heart risk biomarker useful independently, or does it only confirm the results of other tests?
    Health News; 2004 Dec; 10(12):3. PubMed ID: 15645559
    [No Abstract]   [Full Text] [Related]  

  • 7. Statins, cholesterol, women and primary prevention: evidence-based medicine or wishful thinking?
    Eisenberg T; Wells MT
    Future Cardiol; 2009 Jan; 5(1):1-4. PubMed ID: 19371195
    [No Abstract]   [Full Text] [Related]  

  • 8. [Benefits and risks of the new markers for early diagnosis of myocardial infarction].
    Hamm C
    Internist (Berl); 2006 Jun; 47 Suppl 1():S60. PubMed ID: 17598195
    [No Abstract]   [Full Text] [Related]  

  • 9. Cardiology patient page. New blood tests for detecting heart disease.
    Adams J; Apple F
    Circulation; 2004 Jan; 109(3):E12-4. PubMed ID: 14744959
    [No Abstract]   [Full Text] [Related]  

  • 10. Preprocedural high-sensitivity C-reactive protein predicts death or myocardial infarction but not target vessel revascularization or stent thrombosis after percutaneous coronary intervention.
    Delhaye C; Sudre A; Lemesle G; Maréchaux S; Broucqsault D; Hennache B; Bauters C; Lablanche JM
    Cardiovasc Revasc Med; 2009; 10(3):144-50. PubMed ID: 19595394
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On call. I've been hearing a lot about C-reactive protein and heart attacks. I want to stay healthy, but I'm 73 years old, and there seems to be a new worry in every newspaper I read. At my age, does this protein make any difference?
    Simon HB
    Harv Mens Health Watch; 2007 Nov; 12(4):8. PubMed ID: 18217257
    [No Abstract]   [Full Text] [Related]  

  • 12. Multiple biomarkers and cardiovascular risk.
    Austin MJ; Heneghan MA
    N Engl J Med; 2008 Aug; 359(7):760-1; author reply 761. PubMed ID: 18711791
    [No Abstract]   [Full Text] [Related]  

  • 13. Factors associated with C-reactive protein at the early stage of acute myocardial infarction in men.
    García González MJ
    Cardiol J; 2009; 16(4):388; author reply 389. PubMed ID: 19653189
    [No Abstract]   [Full Text] [Related]  

  • 14. Changes in plasma C-reactive protein and hemostatic factors prior to and after a first myocardial infarction with a median follow-up time of 8 years.
    Thøgersen AM; Nilsson TK; Weinehall L; Boman K; Eliasson M; Hallmans G; Jansson JH
    Blood Coagul Fibrinolysis; 2009 Jul; 20(5):340-6. PubMed ID: 19357504
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A new prediction score for myocardial infarction: MINF SCORE.
    Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC; Dumitraşcu DL
    Rom J Intern Med; 2008; 46(2):145-51. PubMed ID: 19284086
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differential impact of admission C-reactive protein levels on 28-day mortality risk in patients with ST-elevation versus non-ST-elevation myocardial infarction (from the Monitoring Trends and Determinants on Cardiovascular Diseases [MONICA]/Cooperative Health Research in the Region of Augsburg [KORA] Augsburg Myocardial Infarction Registry).
    Kuch B; von Scheidt W; Kling B; Heier M; Hoermann A; Meisinger C
    Am J Cardiol; 2008 Nov; 102(9):1125-30. PubMed ID: 18940277
    [TBL] [Abstract][Full Text] [Related]  

  • 17. C-reactive protein concentrations are lower in Singaporeans: implications for risk classification in Asians.
    Hawkins RC
    Clin Chim Acta; 2004 Dec; 350(1-2):241-2. PubMed ID: 15530485
    [No Abstract]   [Full Text] [Related]  

  • 18. Risk factors for heart failure in patients with one prior myocardial infarction episode.
    Mocan T; Agoşton-Coldea L; Gatfossé M; Rosenstingl S; Mocan LC
    Rom J Intern Med; 2008; 46(3):213-21. PubMed ID: 19366080
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [What makes the hearts of women so special. The Eva infarct does not follow the textbook].
    MMW Fortschr Med; 2006 Feb; 148(6):11. PubMed ID: 16526332
    [No Abstract]   [Full Text] [Related]  

  • 20. C-reactive protein and lesion morphology.
    Tousoulis D; Pitsavos C; Stefanadis C
    Circulation; 2004 Mar; 109(9):e153; author reply e153. PubMed ID: 15007022
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.